Drug Profile
Busulfan intravenous - SuperGen
Alternative Names: Busulfan PartajectLatest Information Update: 16 Feb 2022
Price :
$50
*
At a glance
- Originator SuperGen
- Class Antineoplastics; Butylene glycols; Glycols; Mesylates; Myeloablative agonists; Small molecules
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bone marrow transplant rejection; CNS cancer